157 related articles for article (PubMed ID: 15126085)
1. CRF-receptor 1 blockade attenuates acute posttraumatic hyperglycemia in rats.
Hager P; Hagman B; Wikström AC; Strömmer L
J Surg Res; 2004 Jun; 119(1):72-9. PubMed ID: 15126085
[TBL] [Abstract][Full Text] [Related]
2. Preoperative glucocorticoid administration attenuates the systemic stress response and hyperglycemia after surgical trauma in the rat.
Hager P; Permert J; Wikström AC; Herrington MK; Ostenson CG; Strömmer L
Metabolism; 2009 Apr; 58(4):449-55. PubMed ID: 19303963
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
[TBL] [Abstract][Full Text] [Related]
4. Endocrine control of stress-induced heat shock protein 70 expression in vivo.
Udelsman R; Blake MJ; Stagg CA; Holbrook NJ
Surgery; 1994 May; 115(5):611-6. PubMed ID: 8178260
[TBL] [Abstract][Full Text] [Related]
5. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
Doyon C; Samson P; Lalonde J; Richard D
J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
[TBL] [Abstract][Full Text] [Related]
6. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
Huang Q; Timofeeva E; Richard D
J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401
[TBL] [Abstract][Full Text] [Related]
7. An experimental model of intestinal resection and compensated non-hypotensive blood loss.
Hager P; Permert J; Strömmer L
J Surg Res; 2009 Jun; 154(1):1-8. PubMed ID: 19201422
[TBL] [Abstract][Full Text] [Related]
8. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
Kale AY; Paranjape SA; Briski KP
Neuroscience; 2006 Jun; 140(2):555-65. PubMed ID: 16626867
[TBL] [Abstract][Full Text] [Related]
9. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
[TBL] [Abstract][Full Text] [Related]
10. Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3'-kinase activity in rats.
Le Foll C; Corporeau C; Le Guen V; Gouygou JP; Bergé JP; Delarue J
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1223-30. PubMed ID: 17179391
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.
Corporeau C; Foll CL; Taouis M; Gouygou JP; Bergé JP; Delarue J
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E78-E86. PubMed ID: 16339925
[TBL] [Abstract][Full Text] [Related]
12. Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation.
Hoy AJ; Bruce CR; Cederberg A; Turner N; James DE; Cooney GJ; Kraegen EW
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1358-64. PubMed ID: 17785505
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
[TBL] [Abstract][Full Text] [Related]
14. Altered corticosteroid metabolism differentially affects pituitary corticotropin response.
Hanafusa J; Mune T; Tanahashi T; Isomura Y; Suwa T; Isaji M; Daido H; Morita H; Murayama M; Yasuda K
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E466-73. PubMed ID: 11788380
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
Saito K; Kasai T; Nagura Y; Ito H; Kanazawa M; Fukudo S
Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
[TBL] [Abstract][Full Text] [Related]
16. Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation.
Tulipano G; Rizzetti C; Bianchi I; Fanzani A; Spano P; Cocchi D
Neuroendocrinology; 2007; 85(2):61-70. PubMed ID: 17374945
[TBL] [Abstract][Full Text] [Related]
17. Suppression of adrenocorticotrophic hormone secretion by simultaneous antagonism of vasopressin 1b and CRH-1 receptors on three different stress models.
Ramos AT; Troncone LR; Tufik S
Neuroendocrinology; 2006; 84(5):309-16. PubMed ID: 17135717
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.
Spiga F; Harrison LR; Wood S; Knight DM; MacSweeney CP; Thomson F; Craighead M; Lightman SL
J Endocrinol; 2009 Mar; 200(3):273-83. PubMed ID: 19008333
[TBL] [Abstract][Full Text] [Related]
19. Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress.
Uresin Y; Erbas B; Ozek M; Ozkök E; Gürol AO
J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):93-6. PubMed ID: 15295722
[TBL] [Abstract][Full Text] [Related]
20. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
